Gene Networks Implicated in Autism, ADHD, Schizophrenia
the Psychiatry Advisor take:
An analysis of DNA from thousands of patients might offer new targets for developing drugs for autism and other neurological disorders, including attention-deficit/hyperactivity disorder and schizophrenia.
The study, published in Nature Communications, compared more than 6,700 patients with autism to 12,500 control subjects and identified three gene families that play functional roles in the disorder -- the CALM1 network, the MXD-MYC-MAX gene network, and the GRM gene family.
The research team is planning a clinical trial in selected ADHD patients of a drug that activates the glutamate receptor metabotropic (GRM) pathway.
"If drugs affecting this pathway prove successful in this subset of patients with ADHD, we may then test these drugs in autism patients with similar gene variants," said study researcher Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at the Children's Hospital of Philadelphia.
Identification of new gene involved in Parkinson's disease may result in new treatments
A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism, attention-deficit/hyperactivity disorder and schizophrenia.
"Neurodevelopmental disorders are extremely heterogeneous, both clinically and genetically," said study leader Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at The Children's Hospital of Philadelphia (CHOP).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation